Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,224.1
19.5 (0.61%)

 

  • STI Straits Times Index
    3,224.1
    19.5 (0.61%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,583.3
    -0.9 (-0.05%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,597.2
    -441.1 (-1.69%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,559.2
    -38.4 (-1.07%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,098.2
    -7.8 (-0.03%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,608.3
    -48.6 (-0.73%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,027.6M
  • Value: 618.1M
  • Rise: 175
  • Fall: 120
  • Unch: 456

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Tritech0.027+0.004
Koh Eco0.069+0.012
Raffles Edu0.069+0.010
Vividthree0.070+0.025
Boldtek0.114+0.005
GKE0.146+0.007
ThaiBev0.725+0.010
Zhongxin Fruit0.052+0.007
Progen0.054+0.003
Hatten Land0.062-0.001

World Indices

World Indices
Name Last Change
Nasdaq 15,235.7 +9.0
HSI 25,592.9 -445.4
HSCEI 9,081.5 -177.9
Jakarta 6,608.8 -48.1
Nikkei 225 29,098.2 -7.8
SSE Comp 3,560.9 -36.8
Shanghai A 3,731.9 -38.6
Shanghai B 276.1 -1.2
KOSPI 3,025.5 -23.6

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

UGHealthcare UG HEALTHCARE CORPORATIONLTD
Quotes 10 Minutes Delayed. Updated at 27 Oct 2021 15:02
Last (SGD): 0.330 Change: -0.005 High: 0.340 Remarks: CD
Remarks legend:
RemarksDescriptionRemarksDescription
SuspSuspendedIMMImmediate Delivery
PLPending ListingPAPending Announcement
DLDelistedCTConditional Trading
CWConditional When IssueWIWhen Issue
BIBuyIn OnlyJAdjust
HTrading HaltCDCum Dividend
XDEx DividendCBCum Bonus
XBEx BonusCRCum Rights
XREx RightsCOCum Offer
XOEx OfferCECum Entitlement
XEEx EntitlementCICum Interest
XIEx InterestCACum All
XAEx AllSCScripless Conversion
CIRBCircuit Breaker TriggeredCIRHHalt due to Circuit Breaker Triggered
Change (%): -1.49 Low: 0.330
Open 0.340 Yesterday's Close 0.335
Buy Price 0.330 Sell Price 0.335
Buy Volume ('000) 732.8 Sell Volume ('000) 424.1
Cumulative Volume ('000) 357.8 Cumulative Value 118,526
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.19272 Trailing EPS (SGD) e 0.19272 NAV (SGD) b 0.3093
PE a 1.712 Trailing PE f 1.712 Price / NAV b 1.0669
Dividend (SGD) d 0.005110 Cash In Hand (SGD) g 0.1100 Issued & Paid-up Shares c 616,259,000
Dividend Yield (%) d 1.548 Price / Cash In Hand g 3.000 Treasury Shares h -
Beta - 75 Daysi 1.134 R-Squared - 75 Days(%)i 7.43 Market Cap (M) 203.365
Beta - 500 Daysi 0.039 R-Squared - 500 Days (%)i - Enterprise Value (M) 155.791
Piotroski F Score 7 Exchange Code 8K7 Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 54.7679 6-Month VWAP 0.581 Free Float (%) 19.3
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 15 Oct 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference UGHealthcare SGX 203.365 1.712 1.712 1.0669 1.548
Industry Medical & Biotechnology SGX 1,018.602 18.840 16.097 1.4347 1.919
Medical Specialties SGX 1,255.133 2.669 2.703 3.0956 20.705
Index FTSE ST Catalist Index SGX 64.648 30.386 23.409 1.4479 1.802
Local Peer Top Glove SGX 6,966.176 2.737 2.737 3.5714 21.809
Local Peer Medtecs Intl SGX 204.904 1.177 1.407 0.8163 17.993
Local Peer Biolidics SGX 52.825 - - 10.0000 -
Local Peer Yunnan Energy SGX 46.549 - - 1.4359 -
Local Peer Annica SGX 16.675 - - 5.0000 -
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 239,332.514 37.542 27.842 6.4941 0.146
Global Peer ABBOTT LABORATORIES NYSE 227,151.427 50.783 31.461 - 1.193
Global Peer DANAHER CORP NYSE 219,325.119 62.486 38.330 5.4582 0.233
Global Peer MEDTRONIC PLC NYSE 166,947.731 46.297 42.995 3.2426 1.950
Global Peer INTUITIVE SURGICAL INC NASDAQ 124,476.136 117.364 73.689 10.9085 -
Global Peer STRYKER CORP NYSE 103,015.085 64.425 49.455 7.4541 0.860
Global Peer EDWARDS LIFESCIENCES CORP NYSE 72,923.143 88.564 49.865 14.2059 -
Global Peer BECTON DICKINSON & CO NYSE 70,749.257 92.241 37.935 2.9316 1.312
Global Peer BOSTON SCIENTIFIC CORP NYSE 63,105.032 - 134.840 3.9584 -
Global Peer IDEXX LABORATORIES INC NASDAQ 55,466.084 95.339 76.206 74.2061 -
Other Global Peers DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), ALCON AG (NYSE), BAXTER INTERNATIONAL INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), STERIS PLC (NYSE), BIO RAD LABORATORIES INC (NYSE), PERKINELMER INC (NYSE), WATERS CORP (NYSE), INSULET CORPORATION (NASDAQ), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), MASIMO CORPORATION (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), ABIOMED INC (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), BRUKER CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), COCHLEAR LTD (ASX), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), MICROPORT SCIENTIFIC CORPORATION (HKEx), TANDEM DIABETES CARE INC (NASDAQ), GLOBUS MED INC (NYSE), SHANDONG WEIGAO GROUP MEDICAL (HKEx), SHOCKWAVE MEDICAL INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), ANGELALIGN TECHNOLOGY INC (HKEx), STEVANATO GROUP S.P.A. (NYSE), INMODE LTD (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), QUIDEL CORP (NASDAQ), TOPGLOV (Bursa), ICU MEDICAL INC (NASDAQ), HARTA (Bursa), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), NEOGEN CORP (NASDAQ), INARI MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), EBOS GROUP (ASX), CONMED CORP (NYSE), NEVRO CORP (NYSE), MERIT MEDICAL SYSTEMS (NASDAQ), CAREDX INC (NASDAQ), HAEMONETICS CORP (NYSE), THE BEAUTY HEALTH COMPANY (NASDAQ), ATRICURE INC (NASDAQ), AXONICS INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), NUVASIVE INC (NASDAQ), HESKA CORP (NASDAQ), OUTSET MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), GLAUKOS CORPORATION (NYSE), LIFETECH SCIENTIFIC CORP (HKEx), VENUS MEDTECH (HANGZHOU) INC (HKEx), BIOLIFE SOLUTIONS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), BUTTERFLY NETWORK INC (NYSE), MICROPORT CARDIOFLOW MEDTECH CORP (HKEx), MESA LABORATORIES INC (NASDAQ), PEIJIA MEDICAL LIMITED (HKEx), LANTHEUS HOLDINGS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), PULMONX CORPORATION (NASDAQ), ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY (HKEx), INOVIO PHARMACEUTICALS INC (NASDAQ), PARAGON 28 INC (NYSE), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), NANOSONICS LIMITED (ASX), KANGJI MEDICAL HLDGS LTD (HKEx), ORTHOPEDIATRICS CORP (NASDAQ), SIGHT SCIENCES INC (NASDAQ), ATRION CORP (NASDAQ), CUE HEALTH INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), SUPERMX (Bursa), LEMAITRE VASCULAR INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), AK MEDICAL HLDGS LTD (HKEx), VIEWRAY INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), VICARIOUS SURGICAL INC (NYSE), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), CERUS CORP (NASDAQ), NANO-X IMAGING LTD (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), SEMLER SCIENTIFIC INC (NASDAQ), CHINA ISOTOPE & RADIATION CORP (HKEx), INOGEN INC (NASDAQ), 908 DEVICES INC (NASDAQ), BIOVENTUS INC (NASDAQ), DERMTECH INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CRYOLIFE INC (NYSE), SISRAM MEDICAL LTD (HKEx), BEIJING CHUNLIZHENGDA MED INST CO (HKEx), MODERN DENTAL GROUP LIMITED (HKEx), SURMODICS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), BRONCUS HOLDING CORPORATION (HKEx), CUTERA INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), INTERCURE LTD (NASDAQ), SI BONE INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), NYXOAH SA (NASDAQ), ANTARES PHARMA INC (NASDAQ), AXOGEN INC (NASDAQ), VAPOTHERM INC (NYSE), SHANGHAI KINDLY MED INSTRS CO LTD (HKEx), ACOTEC SCIENTIFIC HLDGS LTD (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), PAVMED INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), SHANGHAI HEARTCARE MEDICAL TECHNOLO (HKEx), METRICS INCOME OPPORTUNITIES TRUST (ASX), SOLITON INC (NASDAQ), MISONIX INC (NASDAQ), IRADIMED CORP (NASDAQ), STEREOTAXIS INC (NYSE American), AVITA MEDICAL INC (NASDAQ), ZYNEX INC (NASDAQ), SUZHOU BASECARE MEDICAL CORP LTD (HKEx), ACCURAY INCORPORATED (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), NEUROPACE INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), LUCID DIAGNOSTICS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CVRX INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), ATOSSA THERAPEUTICS INC (NASDAQ), SIENTRA INC (NASDAQ), EARGO INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), ONCOCYTE CORP (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), YESTAR HEALTHCARE HOLDINGS CO LTD (HKEx), AROA BIOSURGERY LTD (ASX), TALIS BIOMEDICAL CORP (NASDAQ), PROFOUND MED CORP (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), PW MEDTECH GROUP LIMITED (HKEx), MEDICAL DEVELOPMENT INTL (ASX), ICECURE MEDICAL LTD (NASDAQ), CYTOSORBENTS CORP (NASDAQ), QUOTIENT LTD (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), CONFORMIS INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), CLARITY PHARMACEUTICALS LTD (ASX), IMPEDIMED LIMITED (ASX), TITAN MEDICAL INC (NASDAQ), TELA BIO INC (NASDAQ), CORMEDIX INC (NASDAQ), SOMNOMED LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), INVACARE CORP (NYSE), INTRICOM CORP (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), CYCLOPHARM LIMITED (ASX), ATOMO DIAGNOSTICS LIMITED (ASX), KELFRED HOLDINGS LTD (HKEx), NEURONETICS INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), IRIDEX CORP (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), FONAR CORP (NASDAQ), CRYO-CELL INTERNATIONAL INC (NASDAQ), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), MICRO-X LTD (ASX), RGTBHD (Bursa), VENUS CONCEPT INC (NASDAQ), OPTISCAN IMAGING (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), CLEANSPACE HOLDINGS LTD (ASX), ALPHA PRO TECH (NYSE American), BIOLASE INC (NASDAQ), SDI LTD (ASX), ELECTROMED INC (NYSE American), ENVVENO MED CORP (NASDAQ), VOLITIONRX LIMITED (NYSE American), BIOSIG TECHNOLOGIES INC (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), CHECK-CAP LTD (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), LENSAR INC (NASDAQ), CELSION CORPORATION (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), NEPHROS INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), VINCENT MEDICAL HOLDINGS LTD (HKEx), IMMUCELL CORP (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), AVINGER INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), DIMERIX LTD (ASX), ELECTROCORE INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), BIOMERICA INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), NEOVASC INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), CARDIEX LTD (ASX), ROCKWELL MEDICAL INC (NASDAQ), APPLIED UV INC (NASDAQ), COMPUMEDICS (ASX), EKSO BIONICS HOLDINGS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), DAXOR CORP (NYSE American), RESONANCE HEALTH LTD (ASX), YUNNAN ENERGY INTL CO LTD (HKEx), NUTRIBAND INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), RESPIRI LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), ADVENTA (Bursa), INSPIREMD INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), PLUS THERAPEUTICS INC (NASDAQ), LIFE HEALTHCARE GROUP LTD (HKEx), PETVIVO HLDGS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), LKL (Bursa), VIVEVE MEDICAL INC (NASDAQ), LBT INNOVATIONS LTD (ASX), OVENTUS MEDICAL LTD (ASX), NUWELLIS INC (NASDAQ), ADHERIUM LIMITED (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), TRUSCREEN GROUP LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), RA MEDICAL SYSTEMS INC (NYSE American), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), THERMOGENESIS HOLDINGS INC (NASDAQ), CYANOTECH CORP (NASDAQ), METALICITY LIMITED (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), USCOM LTD (ASX), HUAKANG BIOMEDICAL HLDGS CO LTD (HKEx), STAR EQUITY HOLDINGS INC (NASDAQ), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.020
-5.71 %
10 Days --0.015
-4.35 %
20 Days --0.015
-4.35 %
Medium Term Return 3 Months --0.230
-41.07 %
6 Months --0.380
-53.52 %
1 Year 0.003-0.593
-63.92 %
Long Term Return 2 Years 0.006+0.280
+572.00 %
3 Years 0.006+0.260
+380.00 %
5 Years 0.008+0.230
+238.00 %
Annualised Return Annualised --
+27.58 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.315 - 1.008 Change From 1 Year Low +0.015 % Change From 1 Year Low (%) +4.76
Change From 1 Year High -0.678 % Change From 1 Year High (%) -67.27
2 Years Range 0.044 - 1.145 Change From 2 Years Low +0.286 % Change From 2 Years Low (%) +656.88
Change From 2 Years High -0.815 % Change From 2 Years High (%) -71.17
5 Years Range 0.044 - 1.145 Change From 5 Years Low +0.286 % Change From 5 Years Low (%) +656.88
Change From 5 Years High -0.815 % Change From 5 Years High (%) -71.17
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

UG Healthcare Corporation Limited manufactures and distributes natural latex and nitrile examination gloves. It markets its natural latex and nitrile examination gloves under the Unigloves brand name, as well as under third party labels. The company also distributes ancillary products, such as surgical, vinyl, and cleanroom gloves, as well as face masks and other medical disposables. Its gloves are used in healthcare, food and beverage, and automotive industries. The company markets its products in approximately 50 countries, including Germany, Nigeria, the People's Republic of China, the United States, the United Kingdom, France, Italy, Austria, Switzerland, the Netherlands, Japan, South Korea, Canada, and Brazil. UG Healthcare Corporation Limited was founded in 1989 and is based in Seremban, Malaysia.

IPO Performance

Listing Date 08 Dec 2014 Full Subscription Rate (x) 11.51
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 1.80 Public Offer Subscription Rate (x) 169.08
IPO Price (SGD) a 0.072 First Day Close (SGD) a 0.083 First Week Close (SGD) a 0.077
Current vs IPO Price (%) +358.33 First Day Gain (%) +15.28 First Week Gain (%) +6.94
Notes:
  1. Adjusted for the following: Share Split 3 for 1 on 30/09/2020, Special Dividend S$0.00105 on 2/3/2021

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2021 Jun 2021 Part 1(3.58 MB)
Annual Report 2020 Jun 2020 Part 1(3.07 MB)
Annual Report 2019 Jun 2019 Part 1(3.87 MB)
Annual Report 2018 Jun 2018 Part 1(3.37 MB)
Annual Report 2017 Jun 2017 Part 1(1.68 MB)
Part 2(0.17 MB)
Annual Report 2016 Jun 2016 Part 1(3.32 MB)
Annual Report 2015 Jun 2015 Part 1(1.19 MB)
IPO Prospectus
IPO Prospectus 2014 Dec 2014 Part 1(2.18 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
26 Oct 2021 0.340 0.340 0.325 0.335 2,675,100 0.3342
25 Oct 2021 0.345 0.350 0.340 0.340 357,500 0.3436
22 Oct 2021 0.345 0.350 0.340 0.345 984,200 0.3446
21 Oct 2021 0.345 0.350 0.340 0.340 424,400 0.3433
20 Oct 2021 0.340 0.355 0.340 0.345 2,124,400 0.3466
19 Oct 2021 0.345 0.350 0.340 0.350 1,617,700 0.3452
18 Oct 2021 0.340 0.345 0.335 0.340 847,600 0.3400
15 Oct 2021 0.340 0.345 0.335 0.340 1,563,000 0.3402
14 Oct 2021 0.345 0.345 0.335 0.335 1,793,800 0.3402
13 Oct 2021 0.340 0.345 0.335 0.335 1,294,800 0.3388
12 Oct 2021 0.345 0.345 0.335 0.345 1,063,200 0.3399
11 Oct 2021 0.345 0.350 0.340 0.345 1,113,700 0.3447
08 Oct 2021 0.330 0.360 0.330 0.345 5,547,700 0.3464
07 Oct 2021 0.335 0.340 0.330 0.335 3,011,400 0.3343
06 Oct 2021 0.335 0.335 0.325 0.335 1,356,100 0.3310
05 Oct 2021 0.335 0.340 0.325 0.335 1,034,200 0.3338
04 Oct 2021 0.330 0.340 0.325 0.340 2,692,800 0.3324
01 Oct 2021 0.345 0.345 0.330 0.330 2,717,800 0.3356
30 Sep 2021 0.340 0.355 0.335 0.345 3,814,700 0.3463
29 Sep 2021 0.345 0.345 0.340 0.340 1,483,700 0.3418
28 Sep 2021 0.340 0.355 0.340 0.345 2,502,500 0.3505
27 Sep 2021 0.350 0.355 0.340 0.345 2,186,500 0.3440
Summary
Current 2 Weeks
(13 Oct 2021 to 26 Oct 2021)
0.340 0.355 0.325 0.335 13,682,500 -
Previous 2 Weeks
(29 Sep 2021 to 12 Oct 2021)
0.345 0.355 0.325 0.345 23,835,300 -
4 Weeks from
(01 Sep 2021 to 28 Sep 2021)
0.535 0.540 0.325 0.345 69,060,200 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.